American Society of Clinical Oncology (ASCO)
STARTRADER Named Best Fintech Forex Broker at Forex Expo Dubai 2026
The award, presented at the ninth edition of the region's leading trading gathering, caps a year of continuous product expansion. DUBAI, UAE, Sept. 24, 2026 /PRNewswire/ -- STARTRADER was named Best Fintech Forex Broker at the Forex Expo Dubai Awards, organised by HQMENA and presented during For...
Totaria Highlights Magnesium Nutrition Awareness During Healthy Aging Month
AURORA, Colo., Sept. 15, 2026 /PRNewswire/ -- As September marks Healthy Aging
Month
Sorbent to acquire Kenvue's Stayfree and Carefree business in Australia and New Zealand
MELBOURNE, Australia, Sept. 14, 2026 /PRNewswire/ -- Sorbent Paper Company Pty Ltd ("Sorbent") has signed an agreement with Kenvue's Singaporean subsidiary to acquire its Stayfree and Carefree feminine care business in Australia and New Zealand. Following completion of the transaction, the busine...
Fashion Summit (HK) 2026 "Code the Fashion Forward" at the Hong Kong Palace Museum: Global Fashion Leaders, Innovators, and Local Design Talents Gather, Sharing Insights to Co-create a Green and Smart New Chapter in Fashion
HONG KONG, Sept. 11, 2026 /PRNewswire/ -- Organised by the Clothing Industry Training Authority (CITA) and sponsored by the Cultural and Creative Industries Development Agency (CCIDA) of the Government of the Hong Kong Special Administrative Region, the "Fashion Summit (HK) 2026" was successfully...
MTE HANOI 2026 - GLOBAL TRENDS IMPACTING VIETNAM HOSPITALITY AND REAL ESTATE
HO CHI MINH CITY, Vietnam, Sept. 10, 2026 /PRNewswire/ -- Global challenges and uncertainty are clouding markets worldwide, yet Vietnam's hospitality sector has been one of the strongest performers globally, supported by strong interest from both international visitors and investors. How can it b...
CStone 2026 Interim Results: Accelerating Pipeline 2.0 Execution and Sustained Global Commercial Momentum
CS2009 Achieved Key Clinical Validations for Efficacy and Safety As of August 2026, updated data further confirmed the favorable safety profile of CS2009 and demonstrated strengthened efficacy across multiple key cohorts compared with the data presented at ASCO in May 2026. With expanded patient...
CStone 2026 Interim Results: Accelerating Pipeline 2.0 Execution and Sustained Global Commercial Momentum
CS2009 Achieved Key Clinical Validations for Efficacy and Safety As of August 2026, updated data further confirmed the favorable safety profile of CS2009 and demonstrated strengthened efficacy across multiple key cohorts compared with the data presented at ASCO in May 2026. With expanded patient...
Fosun Pharma Announces 2026 Interim Results
Globalization Accelerates Value Realization of Innovative Drugs SHANGHAI, Aug. 25, 2026 /PRNewswire/ -- On August 25, Fosun Pharma ("the Company", stock code: 600196.SH; 02196.HK) announced its interim results for 2026. In the first half of 2026 ("the Reporting Period", or 1H2026), the Company r...
Singapore Prepares to Host a Major Week for Offshore Energy as World Offshore Week 2026 Approaches
SINGAPORE, Aug. 25, 2026 /PRNewswire/ -- In just over four weeks, World
Offshore Week 2026, part of the FPSO Network, will bring the offshore oil,
energy and marine industries together at Singapore EXPO on 23–24 September 2026.
Senhwa Completes Enrollment in Phase 1b CX-5461 Expansion Trial; CSR Expected in Q1 2027
TAIPEI, Aug. 25, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492) today announced that it has completed enrollment in its Phase 1b expansion trial evaluating pidnarulex (CX-5461) monotherapy in patients with advanced solid tumors harboring BRCA1/2, PALB2, or other homologous recombinati...
3S Bio Announces 2026 Interim Results: Innovation-Driven, Win-Win Collaboration, and Sustainable Growth
SHANGHAI, Aug. 21, 2026 /PRNewswire/ -- 3S Bio (01530.HK) today announced its interim results for the first half of 2026. During the period, the Company recorded revenue of RMB 4.53 billion, representing a year-over-year growth of 3.9%. Net profit attributable to equity holders of the Company rea...
GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma
* Two head-to-head phase III trials demonstrated superior efficacy, including overall survival versus a daratumumab-based triplet in DREAMM-7 * Blenrep, a first-in-class anti-BCMA ADC, could transform treatment as early as first relapse where additional effective treatment options are needed [...
CARsgen Therapeutics Announces 2026 Interim Results
SHANGHAI, Aug. 18, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, has announced its 2026 Interim Results. Business Highlights * Cash and cash equivalents were around RMB1,400 million as of June ...
Early Bird Tickets Now on Sale | ICOMIA & Sinoexpo Unveil 2027 ICOMIA World Marinas Conference (Shanghai) Preliminary Programme
SHANGHAI, Aug. 18, 2026 /PRNewswire/ -- The International Council of Marine Industry Associations (ICOMIA) and Conference hostSinoexpo Informa Markets are pleased to announce the Preliminary Conference Programme for theICOMIA World Marinas Conference 2027 (IWMC2027), taking place in Shanghai, Chi...
Kelun-Biotech Announces 2026 Interim Results
CHENGDU, China, Aug. 17, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", Stock Code: 6990.HK) announces its unaudited consolidated results for the period ended 30 June 2026 (the "Reporting Period"). Key information is as follows: * Re...
Yochanra®, the World's First Innovative Drug to Overcome FGFR Inhibitor Resistance, Makes Its Global Debut in China
NANJING, China and GAITHERSBURG, Md., Aug. 7, 2026 /PRNewswire/ -- TransThera Sciences' Yochanra® is the first drug independently developed in China to address the longstanding global challenge of acquired resistance to FGFR inhibitor therapy in patients with cholangiocarcinoma. On 6 August 2026,...
Herbalgy Trophy Ignites Hong Kong as Football Fever Sweeps the City
Juventus Defeat Chelsea FC 1–0 "Goal-Getter Giveaway" Opens the Door to World-Class Football1, While 5 Children Fulfil Their Dreams as Player Mascots HONG KONG, Aug. 6, 2026 /PRNewswire/ -- The Herbalgy Trophy: Chelsea FC vs Juventus, the headline of the Hong Kong Football Festival 2026 proudly ...
Innovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2α-biased Bispecific Fusion Protein) in Combination with Bevacizumab in Late-Line Advanced Colorectal Cancer in China
SAN FRANCISCO and SUZHOU, China, Aug. 5, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...
Gene Solutions Advances Precision Oncology Education in Malaysia with the ''Beyond Actionable'' Academy
At the Precision Oncology Academy 2026, leading international experts explored how insights from tumour DNA and RNA can reveal treatment opportunities, explain drug resistance, and translate into more confident treatment decisions to improve cancer care. KUALA LUMPUR, Malaysia, Aug. 4, 2026 /PRN...
CellOrigin Unveils Two Novel Solid-Tumor Cell Therapy Candidates at ASCO 2026, Partners with Walvax for In Vivo CAR Clinical Trial
HANGZHOU, China, July 31, 2026 /PRNewswire/ -- CellOrigin, a biotechnology company focused on next-generation in vivo and in vitro cell therapy technologies, has announced two major progresses in both research and strategic partnership. At the 2026 ASCO Annual Meeting, CellOrigin's scientific co...
Week's Top Stories
Most Reposted
OceanaGold Reports Third Quarter 2026 Results
[Picked up by 1141 media titles]
2026-11-05 06:52Royal Bank of Canada announces agreement to acquire Yarra Capital Management
[Picked up by 1141 media titles]
2026-11-09 21:00Algolia Powers Orange with AI Agents for Billing Support: NYSE Content Update
[Picked up by 1121 media titles]
2026-11-06 22:06Cision Report Reveals the Consumer Trends Hidden Between Search, Social, and AI
[Picked up by 1105 media titles]
2026-11-09 23:00Overstory Launches Integrated AI Platform to Deliver First Living Model of Grid Risk
[Picked up by 1083 media titles]
2026-11-03 22:00